Congrats Melanie Königshoff and Naftali Kaminski

We are excited to announce that Yale School of Medicine and University of Pittsburgh have been selected to join the Three Lakes Consortium for Pulmonary Fibrosis (TLC4PF). Together we will focus on advancing disease understanding and accelerating new treatments for PF: prn.to/30UDleg

We have collaborated with Mayo Clinic to advance diagnosis and treatment of pulmonary fibrosis. This collaboration will be led by Dr. Andrew Limper at the Mayo Clinic. apnews.com/press-release/…

#ThreeLakesFoundation is collaborating with Mayo Clinic to advance diagnosis and treatment of pulmonary fibrosis. This collaboration will be led by Dr. Andrew Limper at the Mayo Clinic. prnewswire.com/news-releases/…

Congratulations to my colleague and collaborator Sydney Montesi from Mass General Research Institute for her 2nd place award for her collagen targeted PET imaging of IPF from Three Lakes Foundation Innovation Challenge for Pulmonary Fibrosis. prnewswire.com/news-releases/… #IPF #MolecularImaging MGH Martinos Center

Congratulations to the winners of the 2020 Innovation Challenge for Pulmonary Fibrosis! Read about the winners and their innovative solutions to accelerate diagnosing, treating, and managing pulmonary fibrosis. Three Lakes Foundation MATTER prnewswire.com/news-releases/…

1,468 people are waiting for a lung transplant. Hear the story of Nick Brown as he shares his journey getting diagnosed with pulmonary fibrosis and his struggle getting a double lung transplant in 'Second Wind': bit.ly/38SA3gW

Join Three Lakes Foundation and MATTER tomorrow for an all-day pitch day to hear finalists of the 2020 Pulmonary Fibrosis Innovation Challenge present solutions to expert judges for a chance at up to $50,000 and a free one-year membership at MATTER.
eventbrite.com/e/pulmonary-fi…

IPF cough in a COVID world: even more implications

Paving the fast track to results by reducing obstacles

Great to be a part of this innovative work

Proud to be a part of exciting progress in the pursuit of new treatments for pulmonary fibrosis. advances.sciencemag.org/content/6/28/e…

1/n The #IPFCellAtlas is finally out! We profiled 312,928 cells from 32 IPF, 28 controls, 18 COPD lungs using 10x Genomics #scRNAseq & identified previously unidentified populations of epithelial & endothelial cells enriched in IPF #CureIPF advances.sciencemag.org/content/6/28/e…

We've teamed up with Three Lakes Foundation to source & amplify stories of people living with #pulmonaryfibrosis . Select participants will win $500 and work with startups to help them create new #PF solutions. Learn more: bit.ly/3clkX1p
#PF perspectives

Proud to be a part of this important work

Naftali Kaminski PF Warrior Cormac Sheridan Nature Biotechnology Action for Pulmonary Fibrosis Toby Maher @3LakesPartners Melanie Königshoff Scott Turner Leticia Kawano-Dourado NIH NHLBI This is truly one HUGE partnership. All of us in the PF space working together toward a cure and to ensure that our patients and caregivers currently on this journey have the resources and the support they need to have quality and the best care while they #LIVEwithPF . ❤️💙💚

Excited to announce the PF Innovation Challenge! #CurePF #teamworkinILD #entrepreneurs

Three Lakes Partners is now Three Lakes Foundation: Three Lakes Foundation

Developing a Healthy Attitude with Pulmonary Fibrosis pf.responsum.com/2018/07/30/dev…

Is this the most important underrated paper in Pulmonary Research this year? I think it is. Kudos Dr. Ivan Rosas & team for this. Important methods paper on “Biobanking and Cryopreservation of Human Lung Explants for Omic Analysis” erj.ersjournals.com/content/early/…